Christopher F. Wyatt - Jan 31, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Controller
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jan 31, 2024
Transactions value $
-$813,950
Form type
4
Date filed
2/2/2024, 06:53 PM
Previous filing
Feb 22, 2023
Next filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $220K +2.68K +7.43% $81.96 38.8K Jan 31, 2024 Direct
transaction HCA Common Stock Options Exercise $910K +9K +23.22% $101.16 47.8K Jan 31, 2024 Direct
transaction HCA Common Stock Tax liability -$1.94M -6.38K -13.35% $304.90 41.4K Jan 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -2.68K -100% $0.00* 0 Jan 31, 2024 Common Stock 2.68K $81.96 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -9K -49.18% $0.00 9.3K Jan 31, 2024 Common Stock 9K $101.16 Direct F2
transaction HCA Stock Appreciation Right Award $0 +4.4K $0.00 4.4K Jan 31, 2024 Common Stock 4.4K $304.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
F3 The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.